Comparison Between Streptokinase And Heparin Nebulizer In Patients with severe Acute Respiratory Distress Syndrome (ARDS)

Comparison Between Streptokinase And Heparin Nebulizer In Patients with Acute Respiratory Distress Syndrome (ARDS)

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201705002182389

Enrollment

Registered

2017-04-06

Start date

2017-01-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory Acute Respiratory Distress Syndrome

Interventions

streptokinase nebulizer in ARDS

heparin nebulization in ARDS

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: ¿ Adult patients (21- 60 years) Admitted to the ICU with ARDS

Exclusion criteria

Exclusion criteria: ¿ Patients with age less than 21 or more than 60 year ¿ Coagulopathy ¿ Heparin Induced Thrombocytopenia ¿ Previous administration of streptokinase ¿ Known or suspected allergy

Design outcomes

Primary

Measure	Time frame
the average daily ratio of partial pressure of oxygen to FiO2 (PaO2/FiO2) ,lung compliance	—

Secondary

Measure	Time frame
days free of mechanical ventilation , death , discharge	—

Countries

Egypt

Contacts

Public ContactMarwa khaled

assisstent lecturere

dr.marwakhaled86@gmail.com01220032700

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026